%D9%81%D8%B1%D8%B7_%D8%AD%D9%85%D9%84_%D8%A7%D9%84%D8%AD%D8%AF%D9%8A%D8%AFHemocromatosiCategory:HemochromatosisH%C3%A4mochromatose%CE%A5%CF%80%CE%B5%CF%81%CF%86%CF%8C%CF%81%CF%84%CF%89%CF%83%CE%B7_%CF%83%CE%B9%CE%B4%CE%AE%CF%81%CE%BF%CF%85Iron_overloadHemokromatozoHemokromatosi%D9%87%D9%85%D9%88%DA%A9%D8%B1%D9%88%D9%85%D8%A7%D8%AA%D9%88%D8%B2HemokromatoosiH%C3%A9mochromatoseHemocromatose%D7%94%D7%9E%D7%95%D7%9B%D7%A8%D7%95%D7%9E%D7%98%D7%95%D7%96%D7%99%D7%A1HemokromatozaHemochromatosis%E9%89%84%E9%81%8E%E5%89%B0%E7%97%87%D0%93%D0%B5%D0%BC%D0%BE%D1%85%D1%80%D0%BE%D0%BC%D0%B0%D1%82%D0%BE%D0%B7%EC%B2%A0%EA%B3%BC%EC%9E%89%EC%A6%9D%D0%A5%D0%B5%D0%BC%D0%BE%D1%85%D1%80%D0%BE%D0%BC%D0%B0%D1%82%D0%BE%D0%B7%D0%B0IJzerstapelingHemokromatoseHemocromatose%D0%93%D0%B5%D0%BC%D0%BE%D1%85%D1%80%D0%BE%D0%BC%D0%B0%D1%82%D0%BE%D0%B7HemohromatozaHemohromatoza%E0%B8%A0%E0%B8%B2%E0%B8%A7%E0%B8%B0%E0%B9%80%E0%B8%AB%E0%B8%A5%E0%B9%87%E0%B8%81%E0%B9%80%E0%B8%81%E0%B8%B4%E0%B8%99%D0%93%D0%B5%D0%BC%D0%BE%D1%85%D1%80%D0%BE%D0%BC%D0%B0%D1%82%D0%BE%D0%B7GemoxromatozQ2025687%E8%A1%80%E8%89%B2%E6%B2%89%E8%91%97%E7%97%85
about
Ludwig van BeethovenCombination Deferasirox and Deferiprone for Severe Iron Overload in ThalassemiaEvaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over LoadCardiac T2* in Beta-thalassemia Patients on Deferasirox TreatmentStudy Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron OverloadSafety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron OverloadTransfusional Iron Overload Among Leukemia SurvivorsClinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaIron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaEfficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension StudyThe Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin LevelsStudy of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease PatientsStudy of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic PatientsChelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl HydrazoneMassive Iron Deposit AssessmentEffects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload PatientsSafety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic AnemiaIron Metabolism in Small Pre Term NewbornsSafety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron OverloadOpen-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron OverloadPhlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic CirrhosisMyelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability StudyHigh-Tc Susceptometer to Monitor Transfusional Iron OverloadEffects of Polyphenols on Iron Absorption in Iron Overload Disorders.A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary HemochromatosisExtended Evaluation of Deferasirox Film-coated Tablet (FCT) FormulationSafety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron OverloadSP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare AnemiasValidation of a Point-of-care Device Measuring Ferritin With Capillary BloodSafety and Efficacy of Early Treatment With Deferiprone in Infants and Young ChildrenChanges in Pituitary Iron and Volume With DeferasiroxDeferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesEfficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron OverloadThis Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.Fetal Parenchymatic Evaluation (Liver, Spleen) Using T2* SequencesAssessment of Iron Deposition in Major Organs of Hemodialysis PatientsSafety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron OverloadDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadIron Overload in Pediatric Oncology PatientsSafety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study
P1050
P2175
P509
Iatrogenic Iron Overload in Dialysis Patients at the Beginning of the 21st CenturyEfficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromesProfile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromesIron Homeostasis in Health and DiseaseOxidative stress in β-thalassaemia and sickle cell diseaseTreating iron overload in patients with non-transfusion-dependent thalassemiaMRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and PitfallsCurrent Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.Iron overload in diabetic retinopathy: a cause or a consequence of impaired mechanisms?Iron, meat and health.Iron and thrombosisThe impact of iron overload and its treatment on quality of life: results from a literature review.Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea.Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.What is new in iron overload?The Role of Iron and Iron Overload in Chronic Liver Disease.Out of balance--systemic iron homeostasis in iron-related disordersBody iron metabolism and pathophysiology of iron overload.Prooxidant mechanisms in iron overload cardiomyopathy.Relationship between Hepatitis C Virus Infection and Iron Overload.Ferroportin disease: pathogenesis, diagnosis and treatment.Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.Effects of Iron Overload and Oxidative Damage on the Musculoskeletal System in the Space Environment: Data from Spaceflights and Ground-Based Simulation ModelsBamboo Stems ( variety henosis) Containing Polyphenol Mixtures Activate Nrf2 and Attenuate Phenylhydrazine-Induced Oxidative Stress and Liver InjuryImbalance of erythropoiesis and iron metabolism in patients with thalassemiaHydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia
P921
Q255-e0cdc658-4f6d-2d1e-aa5c-40e7b61bcefeQ61713081-3EF0006D-061A-4AE0-B115-C1C120892A79Q61920857-1857BA91-12B9-4DBA-A3D4-7A78D6EC14D5Q61924281-073D8F60-66D6-47DB-8336-B639AD0AF189Q61955967-4AE180DF-022C-473B-B998-D8976DC5C7CDQ61965762-BF755E00-D8BF-49CB-A753-B1B762FAD574Q61975784-43DB25A9-AA19-49E5-8445-985DBAB901CDQ61979025-1C101E1C-40AE-4471-8389-87DF5851E09FQ61979050-DF3BF335-1FD8-4AD1-9E44-BCCEAA1DB29FQ61980429-A0567246-270E-480D-BE87-760D242381A0Q62030704-FA95A27A-0AC4-495C-80F5-9D6A3A3EA251Q62105239-4690E78C-BD23-4107-9872-96859B73BF28Q62105276-F084DFEE-F534-4BC2-A43B-8FE1A56D9F07Q62105642-EA563EE1-BEC1-4514-9C18-A2055739176EQ63316215-696E8312-8838-4A5C-8C8A-E90EA0FFDAB8Q63316239-13F09D82-3212-4851-BD7E-3DF584544BCBQ63316984-C92CDD1E-0FBD-4778-9F53-F5CE517E51A9Q63322026-35F91179-C083-4F08-A865-3425B4CDAEA0Q63334338-AF52DE9C-F16F-449B-8CE5-F59919D5C105Q63336306-8DB64574-E51F-4E90-B4DF-41ADD2F02577Q63337442-C79E944A-9CA5-4748-BB66-3973DA3E898FQ63338867-98F6F5E1-0766-4ABD-A004-CA4922B9C719Q63340219-D0A295FD-734D-44EE-83CF-81B9C668E51BQ63400562-0DDD4E89-9228-4C33-A46A-DA203321C412Q63403788-5B9E0338-845F-4936-B719-0D401518C9D0Q63578138-26F50079-289B-48FC-922E-71591A0E810EQ63578697-4EC61DC3-0D64-4098-8AAD-C4F777082D04Q63591448-FC9CEA3E-B88A-4907-B223-C622D83DB496Q63591619-85D15216-9BBE-4C78-936E-A1874B4E5AC3Q63599300-D3893FA2-0DBA-4B09-9672-C05AA5D0D68EQ63812611-F4B48C06-1C95-4F4F-B718-0BF6E0D7BBD4Q63815432-B13715EC-E7D9-4C57-A3DE-7FB945BF4442Q63818448-14C52748-39D6-4A13-B974-92101A6AE906Q63818940-67D1E2BF-78C1-4988-881C-5FDA02F13C33Q63830108-77BCD7C8-B8D8-4562-8783-FDCD041D4748Q63831933-995D791B-6BF9-44CD-9931-6D8C2656B5B8Q63834071-9C83EB59-8976-4237-ADAB-D5A1A1455719Q63834695-5D58862A-5300-4CBC-91E7-11AC4F32A5A9Q63835943-0740179F-1875-4CBA-AC5C-7F30B7ADEBEFQ63836079-F2B6EED0-B004-4BA1-9287-C656BEE3ED44
P1050
description
Erkrankung des Menschen
@de
human disease
@en
malattia del fegato
@it
regroupe les hémochromatoses génétiques et les surcharges en fer acquises
@fr
örökletes anyagcsere-betegség
@hu
Κατάσταση στην οποία τα αποθέματα σιδήρου στον οργανισμό είναι πάνω από το φυσιολογικό.
@el
داء تَرسُب الأصبغة الدموية الوراثي
@ar
name
Dedna hemokromatoza
@sl
Eisenüberschuss
@de
Gemoxromatoz
@uz
Haemacrómatóis cineál 1
@ga
Hemochromatosis
@hu
Hemochromatoza
@pl
Hemocromatose
@gl
Hemocromatose
@pt-br
Hemohromatoza
@sh
Hemohromatoza
@sr
type
label
Dedna hemokromatoza
@sl
Eisenüberschuss
@de
Gemoxromatoz
@uz
Haemacrómatóis cineál 1
@ga
Hemochromatosis
@hu
Hemochromatoza
@pl
Hemocromatose
@gl
Hemocromatose
@pt-br
Hemohromatoza
@sh
Hemohromatoza
@sr
altLabel
Hemochromatose
@nl
Hämochromatose
@de
arveleg hemokromatose
@nn
erverva hemokromatose
@nn
genetisk hemokromatose
@nn
hemokromatózis
@hu
hereditary haemochromatosis
@en
hereditær hemokromatose
@nn
hémochromatose héréditaire
@fr
iron overload (disorder)
@en
prefLabel
Dedna hemokromatoza
@sl
Eisenüberschuss
@de
Gemoxromatoz
@uz
Haemacrómatóis cineál 1
@ga
Hemochromatosis
@hu
Hemochromatoza
@pl
Hemocromatose
@gl
Hemocromatose
@pt-br
Hemohromatoza
@sh
Hemohromatoza
@sr
P279
P227
P486
P508
P646
P672
P1296
P1417
science/hemochromatosis
P1748
P1995
P227
P31
P3219
hemochromatoses
P373
Hemochromatosis
P3827
hemochromatosis
iron-overload
P486
P493
P604
P646
P672
C18.452.565.500